Canada’s innovative pharmaceutical industry association has expressed concern over the federal government’s newly introduced bill that lays the foundation of a universal single-payer pharmacare system and could make it easier to negotiate lower drug prices.
“Moving provinces towards a single-payer system, where drug coverage could be reduced to the lowest common denominator, would limit patient access to new treatments,” Innovative Medicines Canada said of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?